Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001558370-22-002704
Filing Date
2022-03-03
Accepted
2022-03-02 21:17:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tmb-20220302x424b5.htm 424B5 471368
2 GRAPHIC tmb-20220302x424b5004.jpg GRAPHIC 2569
3 GRAPHIC tmb-20220302x424b5003.jpg GRAPHIC 2574
4 GRAPHIC tmb-20220302x424b5001.jpg GRAPHIC 4530
  Complete submission text file 0001558370-22-002704.txt   486454
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-259862 | Film No.: 22706484
SIC: 2834 Pharmaceutical Preparations